Morgan Stanley Reaffirms 'Overweight' Stance on MGM China, Keeps HK$13.5 Target Price

Stock News06-22

Morgan Stanley has issued a research report reiterating its 'Overweight' rating on MGM CHINA (HKEX: 02282), maintaining a target price of HK$13.5.

The firm believes the recent pullback in the stock's price has made its short-term valuation more attractive, and it anticipates the share price will outperform its peers over the next 60 days.

Morgan Stanley points out that MGM China's current valuation is quite compelling, trading at approximately 6 times its projected 2026 enterprise value to EBITDA, with a free cash flow yield to shareholders of around 13%.

Additionally, the company offers a dividend yield exceeding 6%, and Morgan Stanley expects there is further room for dividend growth.

The investment bank also forecasts that MGM China's second-quarter EBITDA for this year will surpass general market expectations.

Beyond maintaining a relatively high market share, MGM China has also achieved the highest return on capital within Macau's gaming sector, reflecting its leading operational efficiency among industry peers.

Morgan Stanley assesses the probability of these positive scenarios materializing at approximately 80% or higher, categorizing it as "very likely" to occur.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment